Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

Figure 2

Effect of HER family and IGF-IR growth factors on the growth of human pancreatic cancer cell lines as percentage of control growth (*, p<0.05, **, p<0.01). Cells were treated with 40 nM of EGF, TGFα, AR, Epigen, HB-EGF, Epiregulin, BTC, NRG-1, IGF-I, IGF-II or Insulin for 72 h in growth medium supplemented with 2% FBS. Results are expressed as percentage of control cells (no treatment) calculated as described in the Materials and Methods.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us